Author

Ahmad Abboud

ORCID 0000-0001-5002-499XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Iman DallouliD· 1 shared Mahmoud AbdelsalamiD· 1 shared Zeinab DallouliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Iman DalloulORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioinformaticsbioRxivPreprintJun 30, 2026

Real-World Progression-Free Survival with Erlotinib versus Osimertinib in EGFR L858R+T790M Compound Mutation Non-Small Cell Lung Cancer: An Exploratory Analysis of the MSK-CHORD Dataset

Zeinab Dalloul, Ahmad Abboud, Iman Dalloul, Mahmoud Abdelsalam

This paper analyzes real-world progression-free survival in EGFR L858R+T790M compound mutation NSCLC patients treated with erlotinib or osimertinib, finding no osimertinib advantage and a significant cross-cohort interaction.

DOI 10.64898/2026.06.25.734551

humanbulk RNA-seq

𝕏 PostBluesky